Moderna and Merck Report Melanoma Vaccine Success in Large Trial
Moderna and Merck report their personalized mRNA melanoma vaccine succeeded in a large clinical trial, a milestone for mRNA cancer immunotherapy in skin cancer.
Topic
Cancer Immunotherapy
Topic
Cancer Immunotherapy
Penn Tests mRNA Cancer Vaccine: What Dermatology Should Watch
Penn Medicine helped test a promising mRNA cancer vaccine, advancing a platform with direct implications for melanoma adjuvant th…